SEC Form 4 research

CNS Pharmaceuticals, Inc. insider transactions

Issuer	CNS Pharmaceuticals, Inc.
Tickers	CNSP
Reporting owners	15
Officers and directors	6
Last public filing	2026-08-19

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-08-18	2026-05-18	Fisher Michal	P	2,000	$5	Not reported

Officers and directors in the directory

Charles Faith L. — 4 qualifying
Climaco John M — 8 qualifying
Downs Christopher S — 7 qualifying
Evans Carl Anthony — 1 qualifying
Fisher Michal — 1 qualifying
Gumulka Jerzy — 3 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.